Life Sciences Companies Investor Presentations Now Available for On-Demand Viewing

Life Sciences Investor Forum today announced that the presentations from the September 16 th conference are now available for on-demand viewing at LifeSciencesInvestorForum.com.

This virtual event showcased live executive presentations and interactive discussions focused on publicly traded companies in the life sciences industry. The company presentations will be available 24/7 for 90 days. Investors, advisors, and analysts may download shareholder materials from the company's "virtual trade booth".

REGISTER OR LOGIN AT: https://bit.ly/3hFx0MB

September 16 th Presenting Companies:

Presenting Company Ticker(s)
VolitionRx Limited NYSE AMERICAN: VNRX
Avicanna Inc. ( OTCQX: AVCNF | TSX: AVCN)
Alpha Cognition Inc. OTCQB: ACOGF | TSX-V: ACOG
Willow Biosciences Inc. ( OTCQX: CANSF | TSX: WLLW)
Filament Health Corp. ( Pink: FLHLF | NEO: FH)
Novamind Inc. ( OTCQB: NVMDF | CSE: NM)
Salarius Pharmaceuticals, Inc. Nasdaq: SLRX
MedX Health Corp. TSX-V: MDX
Wesana Health Holdings Inc. ( OTCQB: WSNAF | CSE: WESA)
Compass Therapeutics, Inc. OTCQB: CMPX
Else Nutrition Holdings Inc. ( OTCQX: BABYF | TSX-V: BABY)

To facilitate investor relations scheduling and for more information about the program, please visit www.lifesciencesinvestorforum.com .

About Life Sciences Investor Forum
Life Sciences Investor Forum is the leading proprietary investor conference series that provides an interactive forum for Life Sciences companies to meet with and present directly to investors.

A real-time solution for investor engagement, Life Sciences Investor Forum is specifically designed for more efficient investor access. Replicating the look and feel of on-site investor conferences, Life Sciences Investor Forum combines leading-edge conferencing and investor communications capabilities with a comprehensive global investor audience network.

CONTACT
Life Sciences Investor Forum
John M. Viglotti
SVP Corporate Services, Investor Access
(212) 220-2221
johnv@lifesciencesinvestorforum.com


Primary Logo

News Provided by GlobeNewswire via QuoteMedia

The Conversation (0)
avicanna news

Avicanna

Leading Biopharmaceutical Research and Development of Commercialized Cannabinoid-Based Products for Global Markets

Gavel resting on cannabis leaves.

Cannabis Crossroads: Record US Demand Meets Federal Gridlock

The US cannabis industry is at a turning point. State-level legalization and retail growth continue to accelerate, but federal policy remains stalled, leaving businesses navigating both opportunity and uncertainty. Record consumer demand is driving sales, yet outdated regulations, restrictive... Keep Reading...
Cannabis leaf.

10 Biggest Cannabis Stocks in the US and Canada in 2025

After initial optimism for rescheduling in the US, the cannabis market has faced challenges in 2025. Despite signs of support from US President Donald Trump and members of his administration, regulatory uncertainty persists in the US. Companies are shifting focus to match changes in consumer... Keep Reading...
Field of cannabis plants under bright sunlight.

Cannabis Market Update: H1 2025 in Review

The first half of 2025 played out differently than many cannabis market participants expected. Heading into the year, there was optimism that rescheduling in the US would reduce or eliminate challenges, but the industry continued to grapple with persistent federal regulatory uncertainty,... Keep Reading...
Closeup of lush green cannabis leaves.

Thailand Reverses Course on Cannabis, Moves to Recriminalize Amid Political Fallout

Thailand’s groundbreaking experiment with cannabis decriminalization is rapidly unraveling, with the government formally moving to reclassify the plant as a narcotic and ban recreational sales.The decision has sent shockwaves through an industry once projected to be worth over US$1 billion.The... Keep Reading...
Cannabis leaf over map of Australia.

A State-by-State Guide to Cannabis in Australia

Australia federally legalised medicinal cannabis in 2016, and Australia's cannabis market has seen major growth since then.Medical cannabis approvals were up by 120 percent in the first half of 2023 compared to the same period in 2022. Statista forecasts that Australian cannabis revenue will... Keep Reading...
Cannabis leaf on road marked with "2025," with sunlight in the background.

New Cannabis Consumption Trends, Regulatory Shifts Seen Driving Market in 2025

Understanding trends in the cannabis industry is paramount for investors eyeing a market with steady growth potential, but the landscape is complex as products and regulations continue to evolve. Consumption habits are changing as edibles, vaping and THC beverages gain traction, especially among... Keep Reading...

Latest Press Releases

Related News